EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 132 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $4,805,000 | +46.0% | 51,724 | +40.8% | 0.17% | +51.8% |
Q4 2020 | $3,290,000 | -44.0% | 36,724 | -35.5% | 0.11% | -42.0% |
Q3 2020 | $5,880,000 | +25.3% | 56,901 | -4.1% | 0.19% | +50.8% |
Q2 2020 | $4,693,000 | +38.6% | 59,353 | +1.5% | 0.13% | +26.7% |
Q1 2020 | $3,385,000 | +67.4% | 58,479 | +55.9% | 0.10% | +119.6% |
Q4 2019 | $2,022,000 | -38.1% | 37,500 | -40.0% | 0.05% | -37.0% |
Q3 2019 | $3,266,000 | -28.2% | 62,448 | -33.7% | 0.07% | -29.1% |
Q2 2019 | $4,549,000 | -45.7% | 94,148 | -43.2% | 0.10% | -39.1% |
Q1 2019 | $8,374,000 | -18.8% | 165,748 | -4.7% | 0.17% | -23.9% |
Q4 2018 | $10,311,000 | +6.1% | 173,967 | +17.8% | 0.22% | +29.1% |
Q3 2018 | $9,719,000 | +9.5% | 147,663 | -16.0% | 0.17% | +12.4% |
Q2 2018 | $8,875,000 | +27.6% | 175,790 | +33.1% | 0.15% | +27.5% |
Q1 2018 | $6,955,000 | +21.6% | 132,101 | +7.3% | 0.12% | +22.4% |
Q4 2017 | $5,721,000 | +67.5% | 123,112 | +45.8% | 0.10% | +24.1% |
Q3 2017 | $3,415,000 | +58.4% | 84,433 | +32.8% | 0.08% | +51.9% |
Q2 2017 | $2,156,000 | +16.7% | 63,591 | -0.1% | 0.05% | +13.0% |
Q1 2017 | $1,848,000 | -11.6% | 63,634 | 0.0% | 0.05% | -17.9% |
Q4 2016 | $2,090,000 | +4.0% | 63,634 | -0.1% | 0.06% | -3.4% |
Q3 2016 | $2,009,000 | -21.8% | 63,696 | -30.3% | 0.06% | -24.7% |
Q2 2016 | $2,570,000 | -10.7% | 91,369 | +15.4% | 0.08% | -11.5% |
Q1 2016 | $2,878,000 | -15.1% | 79,169 | -6.5% | 0.09% | -9.4% |
Q4 2015 | $3,389,000 | +37.1% | 84,715 | -2.3% | 0.10% | +29.7% |
Q3 2015 | $2,472,000 | -15.5% | 86,726 | -2.3% | 0.07% | -14.9% |
Q2 2015 | $2,924,000 | +5.2% | 88,726 | -8.2% | 0.09% | +2.4% |
Q1 2015 | $2,779,000 | +4.4% | 96,637 | -1.2% | 0.08% | -9.6% |
Q4 2014 | $2,662,000 | +27.1% | 97,763 | -0.5% | 0.09% | +22.1% |
Q3 2014 | $2,094,000 | -1.5% | 98,243 | +3.8% | 0.08% | -3.8% |
Q2 2014 | $2,126,000 | -28.4% | 94,637 | -19.5% | 0.08% | -33.9% |
Q1 2014 | $2,971,000 | +241.1% | 117,515 | +210.2% | 0.12% | +227.0% |
Q4 2013 | $871,000 | – | 37,880 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 1,810,519 | $52,071,000 | 4.06% |
Avoro Capital Advisors LLC | 330,635 | $9,509,000 | 3.65% |
FIDUCIARY MANAGEMENT ASSOCIATES LLC | 766,424 | $22,043,000 | 1.32% |
GREAT POINT PARTNERS LLC | 102,791 | $2,956,000 | 1.30% |
Matarin Capital Management, LLC | 75,380 | $2,167,929,000 | 0.66% |
GLOBEFLEX CAPITAL L P | 89,151 | $2,564,000 | 0.49% |
LaSalle Street Capital Management, LLC | 15,897 | $457,000 | 0.45% |
TFS CAPITAL LLC | 149,318 | $4,294,000 | 0.42% |
TURNER INVESTMENTS LLC | 71,880 | $2,067,000 | 0.37% |
NEW AMSTERDAM PARTNERS LLC/NY | 136,116 | $3,915,000 | 0.32% |